Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

People with alopecia areata often have thyroid autoimmunity.

The woman has a scalp condition causing hair loss.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Exclamation-mark hairs and yellow dots indicate alopecia areata, while follicular ostia loss and white scarring indicate lichen planopilaris and discoid lupus erythematosus.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Targeting specific T cells may help treat alopecia areata.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Corticosteroid injections are the most effective treatment for alopecia areata.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

An 8-year-old boy had both alopecia areata and vitiligo on the same spot on his scalp, which is very rare.

Blocking certain proteins on immune cells may help treat alopecia areata.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

People with alopecia areata may have a higher risk of hearing loss.

Hair growth in alopecia areata is hindered due to impaired cell activity in the surrounding tissue.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

New research is helping develop better treatments for alopecia areata.

Some children may develop hair loss after having COVID-19.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

Targeting CXCL10 may help treat alopecia areata.

Thorough scalp exams are crucial for diagnosing hair loss conditions in people with skin of color.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.